HRAS and BRAF mutation allele frequencies (range 11–46%; mean 29%) were consistent with somatically acquired mutations (i.e., admixed with normal stroma), which we confirmed in three CAA cases by laser microdissection (and PCR/Sanger sequencing) of separate tumor epithelium and stroma (Fig. S2). This evidence concerns the gene HRAS and neoplasm.